BNP Paribas Financial Markets’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.98M | Buy |
|
|||||
|
2025
Q2 | $438K | Sell |
|
|||||
|
2025
Q1 | $776K | Sell |
|
|||||
|
2024
Q4 | $12.4M | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $175M | Buy |
|
|||||
|
2022
Q1 | $174M | Buy |
|
|||||
|
2021
Q4 | $171M | Sell |
|
|||||
|
2021
Q3 | $229M | Sell |
|
|||||
|
2021
Q2 | $239M | Buy |
|
|||||
|
2021
Q1 | $463K | Sell |
|
|||||
|
2020
Q4 | $1.76M | Buy |
|
|||||
|
2020
Q3 | $348K | Sell |
|
|||||
|
2020
Q2 | $394K | Buy |
|
|||||
|
2020
Q1 | $278K | Sell |
|
|||||
|
2019
Q4 | $1.79M | Sell |
|
|||||
|
2019
Q3 | $3.62M | Buy |
|
|||||
|
2019
Q2 | $2.86M | Sell |
|
|||||
|
2019
Q1 | $3.14M | Buy |
|
|||||
|
2018
Q4 | $1.16M | Sell |
|
|||||
|
2018
Q3 | $1.93M | Buy |
|
|||||
|
2018
Q2 | $1.81M | Sell |
|
|||||
|
2018
Q1 | $2.1M | Sell |
|
|||||
|
2017
Q4 | $2.27M | Sell |
|
|||||
|
2017
Q3 | $4.15M | Sell |
|
|||||
|
2017
Q2 | $4.58M | Sell |
|
|||||
|
2017
Q1 | $4.82M | Buy |
|
|||||
|
2016
Q4 | $3.73M | Sell |
|
|||||
|
2016
Q3 | $6.75M | Buy |
|
|||||
|
2016
Q2 | $6.16M | Buy |
|
|||||
|
2016
Q1 | $5.64M | Buy |
|
|||||
|
2015
Q4 | $4.47M | Buy |
|
|||||
|
2015
Q3 | $3.73M | Sell |
|
|||||
|
2015
Q2 | $7.48M | Buy |
|
|||||
|
2015
Q1 | $2.68M | Sell |
|
|||||
|
2014
Q4 | $4.33M | Buy |
|
|||||
|
2014
Q3 | $4.64M | Buy |
|
|||||
|
2014
Q2 | $608K | Sell |
|
|||||
|
2014
Q1 | $665K | Buy |
|
|||||
|
2013
Q4 | $284K | Sell |
|
|||||
|
2013
Q3 | $26.3M | Buy |
|
|||||
|
2013
Q2 | $330K | Buy |
|